Hear about the latest developments in how genomics is influencing the way disease is diagnosed and treated.
There are opportunities to exhibit your expertise at the event contact cjmcn@liverpool.ac.uk for more information.
Speakers: –
| UK Biobank: a unique combination of scale, depth, duration and accessibility | Professor Sir Rory Collins |
| Making healthcare personal – the growing role of genomics and microbiome innovation” | Richard Hebdon |
| Can we integrate Pharmacogenetics in Our Future Health? | Professor David Hunter |
| Pharmacogenomics in Sub-Saharan Africans | Dr Innocent Asiimwe |
| Pharmacogenomics implementation – the RCP-BPS report | Dr Emma Magavern |
| Microbiome in drug response | Dr Daniel Martinez |
| Modelling a 2-stage screen for monogenic familial hypercholesterolaemia using UK Biobank | Jasmine Gratton |
| Implementation of pharmacogenomics –
results of the UPGx Consortium PREVENT project |
Professor Henk-Jan Guchelaar |
| Polygenic risk scores and disease stratification | Professor Douglas Easton |
| Genomics England – looking to the future | Professor Matthew Brown |
| Insights from the metabolome in UK biobank | Dr Heli Julkunen |
| Proteomics in the era of large-scale biobanks | Dr Claudia Langenberg |
| Human cell atlas and its relevance to precision medicine | Prof Muzlifah Haniffa |